DE69423915D1 - Dichtgepackte polykationische ammonium, sulfonium und phosphonium lipide - Google Patents
Dichtgepackte polykationische ammonium, sulfonium und phosphonium lipideInfo
- Publication number
- DE69423915D1 DE69423915D1 DE69423915T DE69423915T DE69423915D1 DE 69423915 D1 DE69423915 D1 DE 69423915D1 DE 69423915 T DE69423915 T DE 69423915T DE 69423915 T DE69423915 T DE 69423915T DE 69423915 D1 DE69423915 D1 DE 69423915D1
- Authority
- DE
- Germany
- Prior art keywords
- sulfonium
- sealed
- lipid
- phosphonium
- polycationic ammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 title abstract 2
- -1 PHOSPHONIUM LIPID Chemical class 0.000 title abstract 2
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940124447 delivery agent Drugs 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/62—Quaternary ammonium compounds
- C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/40—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the same carbon atom of the carbon skeleton, e.g. amino-ketals, ortho esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/12—Sulfonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5449—Polyphosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5463—Compounds of the type "quasi-phosphonium", e.g. (C)a-P-(Y)b wherein a+b=4, b>=1 and Y=heteroatom, generally N or O
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/829—Alcaligenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/171,232 US5674908A (en) | 1993-12-20 | 1993-12-20 | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
PCT/US1994/014475 WO1995017373A1 (en) | 1993-12-20 | 1994-12-14 | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69423915D1 true DE69423915D1 (de) | 2000-05-11 |
DE69423915T2 DE69423915T2 (de) | 2000-10-12 |
Family
ID=22623027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69423915T Expired - Lifetime DE69423915T2 (de) | 1993-12-20 | 1994-12-14 | Dichtgepackte polykationische ammonium, sulfonium und phosphonium lipide |
Country Status (8)
Country | Link |
---|---|
US (8) | US5674908A (de) |
EP (1) | EP0741689B1 (de) |
JP (1) | JPH09510435A (de) |
AT (1) | ATE191452T1 (de) |
AU (1) | AU693507B2 (de) |
CA (1) | CA2179611A1 (de) |
DE (1) | DE69423915T2 (de) |
WO (1) | WO1995017373A1 (de) |
Families Citing this family (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674908A (en) | 1993-12-20 | 1997-10-07 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
US6989434B1 (en) | 1994-02-11 | 2006-01-24 | Invitrogen Corporation | Reagents for intracellular delivery of macromolecules |
US5892071A (en) * | 1994-09-30 | 1999-04-06 | The Reagents Of The University Of California | Cationic transport reagents |
US6008202A (en) * | 1995-01-23 | 1999-12-28 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
US5795587A (en) | 1995-01-23 | 1998-08-18 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
EA001616B1 (ru) | 1995-02-28 | 2001-06-25 | Зе Риджентс Оф Зи Юнивесити Оф Кэлифоньэ | Способ лечения болезни сердца, способ лечения недостаточности периферических сосудов и способ ограничения доставки и экспрессии трансгенной конструкции в определенном органе или структуре |
US6752987B1 (en) | 1995-02-28 | 2004-06-22 | The Regents Of The University Of California | Adenovirus encoding human adenylylcyclase (AC) VI |
US5759519A (en) * | 1995-06-07 | 1998-06-02 | Gen-Probe Incorporated | Method for the intracellular delivery of biomolecules using thiocationic lipids |
US5756352A (en) * | 1995-06-07 | 1998-05-26 | Gen-Probe Incorporated | Thiocationic lipid-nucleic acid conjugates |
US5739271A (en) * | 1995-06-07 | 1998-04-14 | Gen-Probe Incorporated | Thiocationic lipids |
US6051429A (en) | 1995-06-07 | 2000-04-18 | Life Technologies, Inc. | Peptide-enhanced cationic lipid transfections |
US5711964A (en) * | 1995-06-07 | 1998-01-27 | United States Of America | Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D |
US20030069173A1 (en) * | 1998-03-16 | 2003-04-10 | Life Technologies, Inc. | Peptide-enhanced transfections |
CA2222586A1 (en) * | 1995-06-07 | 1996-12-19 | Gen-Probe Incorporated | Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
US5851548A (en) * | 1995-06-07 | 1998-12-22 | Gen-Probe Incorporated | Liposomes containing cationic lipids and vitamin D |
WO1997028817A1 (en) * | 1996-02-09 | 1997-08-14 | Cheng Pi Wan | Receptor ligand-facilitated delivery of biologically active molecules |
DE19605175A1 (de) | 1996-02-13 | 1997-08-14 | Sourovoi Andrej Dr | Lipidverbindungen und deren Verwendung |
US6331617B1 (en) | 1996-03-21 | 2001-12-18 | University Of Iowa Research Foundation | Positively charged oligonucleotides as regulators of gene expression |
US6274313B1 (en) | 1996-03-21 | 2001-08-14 | Pioneer-Hybrid International, Inc. | Oligonucleotides with cationic phosphoramidate internucleoside linkages and methods of use |
US5734040A (en) * | 1996-03-21 | 1998-03-31 | University Of Iowa Research Foundation | Positively charged oligonucleotides as regulators of gene expression |
CA2286177C (en) | 1997-04-07 | 2011-06-21 | Daiichi Pharmaceutical Co., Ltd. | Composition for gene transfer into cells |
US6090619A (en) * | 1997-09-08 | 2000-07-18 | University Of Florida | Materials and methods for intracellular delivery of biologically active molecules |
JP2001523480A (ja) | 1997-11-20 | 2001-11-27 | バイカル インコーポレイテッド | サイトカイン発現ポリヌクレオチドおよびそれらの組成物を用いた癌の処置 |
ATE383331T1 (de) * | 1998-11-12 | 2008-01-15 | Invitrogen Corp | Transportreagentien |
US7683035B1 (en) * | 1999-02-23 | 2010-03-23 | Qiagen, Gmbh | Method of stabilizing and/or isolating nucleic acids |
GB9914085D0 (en) * | 1999-06-16 | 1999-08-18 | Smithkline Beecham Plc | New use |
US6830902B1 (en) | 1999-07-02 | 2004-12-14 | Invitrogen Corporation | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
WO2001048164A2 (en) | 1999-12-27 | 2001-07-05 | The Regents Of The University Of California | Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure |
US7198924B2 (en) | 2000-12-11 | 2007-04-03 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
US20020086849A1 (en) * | 2000-10-27 | 2002-07-04 | Gulilat Gebeyehu | Method for introducing antisense oligonucleotides into eucaryotic cells |
US7294511B2 (en) * | 2001-03-22 | 2007-11-13 | Chromos Molecular Systems, Inc. | Methods for delivering nucleic acid molecules into cells and assessment thereof |
US20030096414A1 (en) * | 2001-03-27 | 2003-05-22 | Invitrogen Corporation | Culture medium for cell growth and transfection |
DE60334618D1 (de) | 2002-06-28 | 2010-12-02 | Protiva Biotherapeutics Inc | Verfahren und vorrichtung zur herstellung von liposomen |
JP2006517790A (ja) * | 2003-01-09 | 2006-08-03 | インヴィトロジェン コーポレーション | ポリペプチド−核酸複合体の細胞の送達および活性化 |
JP4695075B2 (ja) * | 2003-06-18 | 2011-06-08 | イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム | トランスフェクションで使用するためのスフィンゴ脂質ポリアルキルアミン抱合体 |
US7906122B2 (en) * | 2003-06-18 | 2011-03-15 | Yissum Research Development Company Of The Hebrew University Of Jersusalem | Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination |
JP4842821B2 (ja) * | 2003-09-15 | 2011-12-21 | プロチバ バイオセラピューティクス インコーポレイティッド | ポリエチレングリコール修飾脂質化合物およびその使用 |
EP1697534B1 (de) | 2003-12-01 | 2010-06-02 | Life Technologies Corporation | Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon |
EP1718747B1 (de) * | 2004-02-06 | 2009-10-28 | Dharmacon, Inc. | Stabilisierte rnas als transfektionskontrollen und silencing-reagentien |
US20090280567A1 (en) * | 2004-02-06 | 2009-11-12 | Dharmacon, Inc. | Stabilized sirnas as transfection controls and silencing reagents |
US8409590B2 (en) * | 2004-02-11 | 2013-04-02 | Ligocyte Pharmaceuticals, Inc. | Anthrax antigens and methods of use |
CA2556757C (en) * | 2004-02-20 | 2011-05-03 | Aventis Pharmaceuticals Inc. | Oxydecahydronaphthalene modulators of hm74 |
KR101147147B1 (ko) * | 2004-04-01 | 2012-05-25 | 머크 샤프 앤드 돔 코포레이션 | Rna 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드 |
EP1766035B1 (de) | 2004-06-07 | 2011-12-07 | Protiva Biotherapeutics Inc. | Lipidverkapselte interferenz-rna |
US7923206B2 (en) | 2004-11-22 | 2011-04-12 | Dharmacon, Inc. | Method of determining a cellular response to a biological agent |
US7935811B2 (en) | 2004-11-22 | 2011-05-03 | Dharmacon, Inc. | Apparatus and system having dry gene silencing compositions |
US7923207B2 (en) * | 2004-11-22 | 2011-04-12 | Dharmacon, Inc. | Apparatus and system having dry gene silencing pools |
US8143254B2 (en) * | 2005-02-18 | 2012-03-27 | Cornell Research Foundation, Inc. | Methods for modulating ion channels |
EP1868571A4 (de) * | 2005-03-02 | 2011-10-26 | Univ Northeastern | Mitochondriotropische phospholipid-vesikel |
US20060228406A1 (en) * | 2005-03-17 | 2006-10-12 | Invitrogen Corporation | Transfection reagent for non-adherent suspension cells |
US20060223777A1 (en) * | 2005-03-29 | 2006-10-05 | Dharmacon, Inc. | Highly functional short hairpin RNA |
AU2006308765B2 (en) | 2005-11-02 | 2013-09-05 | Arbutus Biopharma Corporation | Modified siRNA molecules and uses thereof |
CA2663601C (en) | 2006-09-22 | 2014-11-25 | Dharmacon, Inc. | Duplex oligonucleotide complexes and methods for gene silencing by rna interference |
US7845686B2 (en) * | 2007-12-17 | 2010-12-07 | S & B Technical Products, Inc. | Restrained pipe joining system for plastic pipe |
AU2008342535B2 (en) * | 2007-12-27 | 2015-02-05 | Arbutus Biopharma Corporation | Silencing of polo-like kinase expression using interfering RNA |
WO2009086558A1 (en) * | 2008-01-02 | 2009-07-09 | Tekmira Pharmaceuticals Corporation | Improved compositions and methods for the delivery of nucleic acids |
US8188060B2 (en) | 2008-02-11 | 2012-05-29 | Dharmacon, Inc. | Duplex oligonucleotides with enhanced functionality in gene regulation |
CA2721333C (en) | 2008-04-15 | 2020-12-01 | Protiva Biotherapeutics, Inc. | Novel lipid formulations for nucleic acid delivery |
AU2009303345B2 (en) | 2008-10-09 | 2015-08-20 | Arbutus Biopharma Corporation | Improved amino lipids and methods for the delivery of nucleic acids |
WO2010083615A1 (en) | 2009-01-26 | 2010-07-29 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing apolipoprotein c-iii expression |
US9018187B2 (en) | 2009-07-01 | 2015-04-28 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
JP5766188B2 (ja) | 2009-07-01 | 2015-08-19 | プロチバ バイオセラピューティクス インコーポレイティッド | 固形腫瘍に治療剤を送達するための脂質製剤 |
US8569256B2 (en) | 2009-07-01 | 2013-10-29 | Protiva Biotherapeutics, Inc. | Cationic lipids and methods for the delivery of therapeutic agents |
US8716464B2 (en) * | 2009-07-20 | 2014-05-06 | Thomas W. Geisbert | Compositions and methods for silencing Ebola virus gene expression |
US8455455B1 (en) | 2010-03-31 | 2013-06-04 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing genes involved in hemorrhagic fever |
US9006417B2 (en) | 2010-06-30 | 2015-04-14 | Protiva Biotherapeutics, Inc. | Non-liposomal systems for nucleic acid delivery |
US8466122B2 (en) | 2010-09-17 | 2013-06-18 | Protiva Biotherapeutics, Inc. | Trialkyl cationic lipids and methods of use thereof |
ES2702428T3 (es) | 2010-11-15 | 2019-02-28 | Life Technologies Corp | Reactivos de transfección que contienen amina y métodos para prepararlos y usarlos |
US9035039B2 (en) | 2011-12-22 | 2015-05-19 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing SMAD4 |
EP3404095B1 (de) | 2012-05-02 | 2022-07-27 | Life Technologies Corporation | Transiente expression mit hoher ausbeute in säugetierzellen mit einmaliger paarung von hochdichtem wachstum sowie einem transfektionsmedium und expressionsverstärkern |
ES2908345T3 (es) | 2013-11-03 | 2022-04-28 | Univ California | Líquidos iónicos para la administración transdérmica de medicamentos |
SG10201811729PA (en) | 2013-12-12 | 2019-02-27 | Life Technologies Corp | Membrane-penetrating peptides to enhance transfection and compositions and methods for using same |
EP3169310A1 (de) | 2014-07-15 | 2017-05-24 | Life Technologies Corporation | Zusammensetzungen mit lipidaggregaten und verfahren zur effizienten bereitstellung von molekülen an zellen |
EP3322813A1 (de) | 2015-07-13 | 2018-05-23 | Life Technologies Corporation | System und verfahren für verbesserte transiente proteinexpression in cho-zellen |
US11085056B2 (en) | 2015-08-28 | 2021-08-10 | Molecular Transfer, Inc. | Transfection complexes and methods of using the same |
US10538784B2 (en) | 2016-03-01 | 2020-01-21 | Molecular Transfer, Inc. | Plant virus movement proteins and methods of using the same |
JP7179354B2 (ja) * | 2016-08-29 | 2022-11-29 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 皮膚処置のためのイオン種に基づく局所処方物 |
JP2018035121A (ja) * | 2016-09-02 | 2018-03-08 | 東ソー株式会社 | カチオン性ジェミニ型界面活性剤 |
CA3036484A1 (en) * | 2016-09-13 | 2018-03-22 | Exigence Technologies Inc. | Antimicrobial compounds or precursors thereof comprising one or more cationic centers and a coating-incorporation group |
WO2020086408A1 (en) | 2018-10-26 | 2020-04-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | A high-yield perfusion-based transient gene expression bioprocess |
WO2020212522A1 (en) | 2019-04-16 | 2020-10-22 | Genfit | Compositions and methods for the stabilization of micro-rna |
US11591544B2 (en) | 2020-11-25 | 2023-02-28 | Akagera Medicines, Inc. | Ionizable cationic lipids |
US20230323395A1 (en) | 2021-12-15 | 2023-10-12 | Homology Medicines, Inc. | Methods and compositions for the production of adeno-associated virus |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE286853C (de) | ||||
US2654785A (en) * | 1949-02-15 | 1953-10-06 | Ciba Pharm Prod Inc | Quaternated aza-pentane amines |
US2901461A (en) | 1955-05-05 | 1959-08-25 | Union Carbide Corp | Curable glycidyl polyether-polyamine compositions |
US2867665A (en) * | 1956-07-09 | 1959-01-06 | Searle & Co | Alkylenebis [trialkylphosphonium halides] and processes for the manufacture thereof |
GB892413A (en) * | 1957-07-15 | 1962-03-28 | Nat Res Dev | Poly-onium neuromuscular blocking agents |
US3152188A (en) | 1960-11-15 | 1964-10-06 | Nalco Chemical Co | Nu-substituted polyalkylene polyamines having 2-hydroxyethyl and mono-secondary-hydroxyl hydrocarbon substituents |
US3324182A (en) * | 1962-12-26 | 1967-06-06 | Monsanto Res Corp | Penta-alkyldialkylenetriamines |
US3369905A (en) * | 1963-03-19 | 1968-02-20 | Eastman Kodak Co | Photographic silver halide emulsions containing polyamine sensitizing agents |
DE1617126C3 (de) | 1967-03-01 | 1975-06-19 | Henkel & Cie Gmbh, 4000 Duesseldorf | Maschinenwaschmittel |
DE2624527A1 (de) * | 1976-06-01 | 1977-12-22 | Bayer Ag | Verfahren zur herstellung von polyurethanen |
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US5049386A (en) * | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US4946787A (en) * | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US5208036A (en) * | 1985-01-07 | 1993-05-04 | Syntex (U.S.A.) Inc. | N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
CA1288774C (en) * | 1985-01-07 | 1991-09-10 | Deborah A. Eppstein | 1,2-dialkoxy-w-trialkylammonium cationic surfactants |
US5545412A (en) | 1985-01-07 | 1996-08-13 | Syntex (U.S.A.) Inc. | N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor |
US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
DD290877A5 (de) * | 1985-11-21 | 1991-06-13 | Univ Ernst Moritz Arndt | Verfahren zur herstellung elektrisch leitender sulfoniumpolyiodide |
US5342945A (en) * | 1986-12-02 | 1994-08-30 | University Of Florida Research Foundation, Inc. | Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives |
US5091576A (en) * | 1986-12-02 | 1992-02-25 | University Of Florida | Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives |
DK0465529T3 (da) | 1989-03-21 | 1998-10-05 | Vical Inc | Ekspression af exogene polynukleotidsekvenser i et hvirveldyr |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US6214804B1 (en) | 1989-03-21 | 2001-04-10 | Vical Incorporated | Induction of a protective immune response in a mammal by injecting a DNA sequence |
FR2645866B1 (fr) * | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | Nouvelles lipopolyamines, leur preparation et leur emploi |
BE1003510A5 (fr) * | 1989-10-09 | 1992-04-07 | Fabricom Air Conditioning Sa | Composition desinfectante et procede de desinfection. |
JP3083842B2 (ja) * | 1989-11-14 | 2000-09-04 | スローン・ケターリング・インスティテュート・フォー・キャンサー・リサーチ | 新規かつ強力な最終分化誘発剤及びその使用方法 |
US5583198A (en) | 1989-12-22 | 1996-12-10 | Commonwealth Scientific And Industrial Research Organization | Amino acids, peptides or derivatives thereof coupled to fats |
US4967008A (en) * | 1990-01-12 | 1990-10-30 | Sherex Chemical Company, Inc. | Polyamines and their preparation |
US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
AU7979491A (en) | 1990-05-03 | 1991-11-27 | Vical, Inc. | Intracellular delivery of biologically active substances by means of self-assembling lipid complexes |
AU628690B2 (en) * | 1990-08-27 | 1992-09-17 | Pratley Investments (Proprietary) Limited | Adhesive primer |
US5283185A (en) | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
US5338837A (en) | 1991-12-13 | 1994-08-16 | The Trustees Of Princeton University | Glycosylated steroid derivatives for transport across biological membranes and process for making same |
EP1236473A3 (de) * | 1992-04-03 | 2003-01-15 | The Regents Of The University Of California | Selbst zusammenbaubares system zur verabreichung von polynukleotiden |
CA2094341A1 (en) * | 1992-04-28 | 1993-10-29 | Carl W. Porter | Methods for the use of spermidine/spermine n1-acetyltransferase as a prognostic indicator and/or tumor response marker |
WO1993024640A2 (en) | 1992-06-04 | 1993-12-09 | The Regents Of The University Of California | Methods and compositions for in vivo gene therapy |
US5334761A (en) * | 1992-08-28 | 1994-08-02 | Life Technologies, Inc. | Cationic lipids |
EP0702516A4 (de) | 1993-06-01 | 1998-04-22 | Life Technologies Inc | Genetische immunisierung mit kationischen lipiden |
WO1995002698A1 (en) | 1993-07-12 | 1995-01-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
US5674908A (en) * | 1993-12-20 | 1997-10-07 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
US6075012A (en) | 1994-02-11 | 2000-06-13 | Life Technologies, Inc. | Reagents for intracellular delivery of macromolecules |
US5651981A (en) | 1994-03-29 | 1997-07-29 | Northwestern University | Cationic phospholipids for transfection |
FR2719316B1 (fr) | 1994-04-28 | 1996-05-31 | Idm | Nouveaux complexes d'acide nucléique et de polymère, leur procédé de préparation et leur utilisation pour la transfection de cellules. |
US5908635A (en) | 1994-08-05 | 1999-06-01 | The United States Of America As Represented By The Department Of Health And Human Services | Method for the liposomal delivery of nucleic acids |
AUPM747694A0 (en) | 1994-08-16 | 1994-09-08 | Commonwealth Scientific And Industrial Research Organisation | Delivery of nucleic acids and peptides |
US5753613A (en) | 1994-09-30 | 1998-05-19 | Inex Pharmaceuticals Corporation | Compositions for the introduction of polyanionic materials into cells |
ATE219660T1 (de) | 1994-09-30 | 2002-07-15 | Inex Pharmaceuticals Corp | Mittel zum einbringen polyanionischer materialien in zellen |
US5627159A (en) | 1994-10-27 | 1997-05-06 | Life Technologies, Inc. | Enhancement of lipid cationic transfections in the presence of serum |
US5650096A (en) | 1994-12-09 | 1997-07-22 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
US5719131A (en) | 1994-12-09 | 1998-02-17 | Genzyme Corporation | Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules |
US5840710A (en) | 1994-12-09 | 1998-11-24 | Genzyme Corporation | Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules |
US5948767A (en) | 1994-12-09 | 1999-09-07 | Genzyme Corporation | Cationic amphiphile/DNA complexes |
US5635487A (en) * | 1994-12-29 | 1997-06-03 | Wolff; Jon A. | Amphipathic, micellar delivery systems for biologically active polyions |
US5795587A (en) | 1995-01-23 | 1998-08-18 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
US5830430A (en) | 1995-02-21 | 1998-11-03 | Imarx Pharmaceutical Corp. | Cationic lipids and the use thereof |
US5830878A (en) | 1995-06-07 | 1998-11-03 | Megabios Corporation | Cationic lipid: DNA complexes for gene targeting |
US20030069173A1 (en) | 1998-03-16 | 2003-04-10 | Life Technologies, Inc. | Peptide-enhanced transfections |
US6051429A (en) | 1995-06-07 | 2000-04-18 | Life Technologies, Inc. | Peptide-enhanced cationic lipid transfections |
WO1996040961A1 (en) | 1995-06-07 | 1996-12-19 | Life Technologies, Inc. | Peptide-enhanced cationic lipid transfections |
US5744335A (en) * | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
US6126964A (en) | 1996-01-04 | 2000-10-03 | Mirus Corporation | Process of making a compound by forming a polymer from a template drug |
AUPN741696A0 (en) | 1996-01-05 | 1996-01-25 | Commonwealth Scientific And Industrial Research Organisation | Delivery of nucleic acids ii |
WO1997042819A1 (en) | 1996-05-13 | 1997-11-20 | Alberto Haces | Cationic lipids for transfection of negatively charged or neutral molecules into living cells |
US5935936A (en) | 1996-06-03 | 1999-08-10 | Genzyme Corporation | Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
US5861397A (en) * | 1996-10-03 | 1999-01-19 | Vical Incorporated | Piperazine based cytofectins |
CA2217550A1 (en) | 1996-10-22 | 1998-04-22 | F. Hoffmann-La Roche Ag | Cationic lipids for gene therapy |
AU738384B2 (en) * | 1996-11-04 | 2001-09-20 | Qiagen Gmbh | Cationic reagents for transfection |
US5948925A (en) | 1997-05-06 | 1999-09-07 | Genzyme Corporation | Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids |
AU3659497A (en) | 1997-07-11 | 1999-02-08 | Canji, Inc. | Organ-specific targeting of cationic amphiphile/retinobl astoma encoding dna complexes for gene therapy |
GB9726073D0 (en) | 1997-12-09 | 1998-02-04 | Smithkline Beecham Plc | Novel compounds |
ATE383331T1 (de) | 1998-11-12 | 2008-01-15 | Invitrogen Corp | Transportreagentien |
EP1165819A2 (de) | 1999-03-31 | 2002-01-02 | Invitrogen Corporation | Verabreichung von funktionellen proteinsequenzen durch verwendung von translokatierenden polypeptiden |
US20020086849A1 (en) | 2000-10-27 | 2002-07-04 | Gulilat Gebeyehu | Method for introducing antisense oligonucleotides into eucaryotic cells |
-
1993
- 1993-12-20 US US08/171,232 patent/US5674908A/en not_active Expired - Lifetime
-
1994
- 1994-12-14 WO PCT/US1994/014475 patent/WO1995017373A1/en active IP Right Grant
- 1994-12-14 JP JP7517507A patent/JPH09510435A/ja not_active Withdrawn
- 1994-12-14 DE DE69423915T patent/DE69423915T2/de not_active Expired - Lifetime
- 1994-12-14 CA CA002179611A patent/CA2179611A1/en not_active Abandoned
- 1994-12-14 AT AT95905957T patent/ATE191452T1/de active
- 1994-12-14 AU AU14372/95A patent/AU693507B2/en not_active Ceased
- 1994-12-14 EP EP95905957A patent/EP0741689B1/de not_active Expired - Lifetime
-
1997
- 1997-01-13 US US08/782,783 patent/US5834439A/en not_active Expired - Lifetime
-
1998
- 1998-11-06 US US09/187,676 patent/US6110916A/en not_active Expired - Lifetime
-
2000
- 2000-08-25 US US09/648,492 patent/US6399663B1/en not_active Expired - Lifetime
-
2002
- 2002-04-23 US US10/131,539 patent/US6716882B2/en not_active Expired - Fee Related
-
2004
- 2004-01-21 US US10/762,914 patent/US7501542B2/en not_active Expired - Fee Related
-
2007
- 2007-10-31 US US11/931,075 patent/US20080207776A1/en not_active Abandoned
-
2009
- 2009-05-21 US US12/470,285 patent/US20090317908A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7501542B2 (en) | 2009-03-10 |
WO1995017373A1 (en) | 1995-06-29 |
EP0741689A1 (de) | 1996-11-13 |
AU1437295A (en) | 1995-07-10 |
EP0741689B1 (de) | 2000-04-05 |
US20040152770A1 (en) | 2004-08-05 |
US6110916A (en) | 2000-08-29 |
US6716882B2 (en) | 2004-04-06 |
ATE191452T1 (de) | 2000-04-15 |
CA2179611A1 (en) | 1995-06-29 |
US6399663B1 (en) | 2002-06-04 |
AU693507B2 (en) | 1998-07-02 |
US20020156049A1 (en) | 2002-10-24 |
US20080207776A1 (en) | 2008-08-28 |
US20090317908A1 (en) | 2009-12-24 |
JPH09510435A (ja) | 1997-10-21 |
US5834439A (en) | 1998-11-10 |
US5674908A (en) | 1997-10-07 |
DE69423915T2 (de) | 2000-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69423915T2 (de) | Dichtgepackte polykationische ammonium, sulfonium und phosphonium lipide | |
ATE178584T1 (de) | Kationische lipide | |
IT1203515B (it) | Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono | |
DK0758248T3 (da) | Formuleringer til faktor IX | |
CA2201120A1 (en) | Polyethylene glycol modified ceramide lipids and liposome uses thereof | |
CA2180816A1 (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
CA2193337A1 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
EP0275005A3 (en) | Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them | |
DE69620877D1 (de) | Arzneimittelformulierungen für il-12 | |
NO954342L (no) | Erytropoietinanalogblandinger, samt fremgangsmåter ved fremstilling derav | |
ATE270557T1 (de) | Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen | |
AU4711296A (en) | Method for loading lipid vesicles | |
SE9704545D0 (sv) | Novel compounds | |
AU7576896A (en) | Lipopolyamines as transfection agents and their pharmaceutical applications | |
SE9704544D0 (sv) | Novel compounds | |
BR9815570A (pt) | Composto, processo de preparação dos compostos, utilização de pelo menos um composto, composição cosmética ou farmacêutica e utilização de pelos menos um polìmero | |
SE9704546D0 (sv) | Novel compounds | |
CA2176713A1 (en) | Amphiphilic Imidazolinium Derivatives | |
CA2003391A1 (en) | Silicone hairspray compositions | |
HUP9700826A1 (hu) | Peptikus fekély elleni gyógyászati készítmények | |
MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
PH30665A (en) | Aminosulfonyl urea acat inhibitors | |
ES478048A1 (es) | Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos. | |
AU7556487A (en) | Immunotoxins, process for their preparation and pharmaceutical compositions in which they are present | |
RU94016184A (ru) | Противоаллергическая композиция для местного глазного применения, способ ее получения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: LIFE TECHNOLOGIES CORP. (N.D.GES.D. STAATES DE, US |
|
8380 | Miscellaneous part iii |
Free format text: PFANDRECHT |
|
8380 | Miscellaneous part iii |
Free format text: PFANDRECHT AUFGEHOBEN |